text.skipToContent text.skipToNavigation

TCI uses cookies to personalize and improve your user experience. By continuing on our website, you accept the use of cookies. You can change or update your cookiesettings at any time.

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 112522-64-2 | Product Number: A2501

Acetyldinaline

×
× Acetyldinaline

Purity: >98.0%(HPLC)
Synonyms:
  • 4-Acetamido-N-(2-aminophenyl)benzamide
Documents:
SDS | Specifications | C of A & Other Certificates | Analytical Charts
10MG
$72.00
 1   1   14  
50MG
$249.00
 Contact Us Contact Us ≥20 

* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.

General Information plus plus
Product Number A2501
Purity / Analysis Method >98.0%(HPLC)
Molecular Formula / Molecular Weight C__1__5H__1__5N__3O__2 = 269.30  
Physical State (20 deg.C) Solid
Storage Temperature 0-10°C
Condition to Avoid Heat Sensitive
CAS RN 112522-64-2
PubChem Substance ID 160871335
MDL Number

MFCD00866266
Specifications & Properties plus plus
Specifications
Appearance Light orange to Yellow to Green powder to crystal
Purity(HPLC) min. 98.0 area%
Elemental analysis(Nitrogen) 15.0 to 16.0 %
Properties (reference)
Melting Point 242 °C(dec.)
Safety & Regulations plus plus
GHS
Related Laws:
RTECS# CU8702023
Transport Information:
HS Number 2924.29.7790
Applications plus plus
Application
Studies of HDAC Inhibitors
References

Chemical phylogenetics of histone deacetylases

J. E. Bradner, N. West, M. L. Grachan, E. F. Greenberg, S. J. Haggarty, T. Warnow, R. Mazitschek, Nat. Chem. Biol. 2010, 6, 238.

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

M. Bantscheff, C. Hopf, M. M. Savitski, A. Dittmann, P. Grandi, A.-M. Michon, J. Schlegl, Y. Abraham, I. Becher, G. Bergamini, M. Boesche, M. Delling, B. Dümpelfeld, D. Eberhard, C. Huthmacher, T. Mathieson, D. Poeckel, V. Reader, K. Strunk, G. Sweetman, U. Kruse, G. Neubauer, N. G. Ramsden, G. Drewes, Nat. Biotechnol. 2011, 29, 255.

Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head

T. Beckers, C. Burkhardt, H. Wieland, P. Gimmnich, T. Ciossek, T. Maier, K. Sanders, Int. J. Cancer 2007, 121, 1138.

Preclinical antitumor activity of CI-994

P. M. LoRusso, L. Demchik, B. Foster, J. Knight, M.-C. Bissery, L. M. Polin, W. R. Leopold III, T. H. Corbett, Invest. New Drugs 1996, 14, 349.

In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines

M. Loprevite, M. Tiseo, F. Grossi, T. Scolaro, C. Semino, A. Pandolfi, R. Favoni, A. Ardizzoni, Oncol. Res. 2005, 15, 39.


PubMed Literature


Articles/Brochures

TCIMAIL
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.
Other Documents